Ascendis Pharma, INC.
Based in CA
🤖
AI Overview
With $3.0M in lobbying spend across 23 quarterly filings, Ascendis Pharma, INC is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2020 to 2025.
$3.0M
Total Spend
6
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $110K |
| 2021 | $500K |
| 2022 | $570K |
| 2023 | $590K |
| 2024 | $540K |
| 2025 | $650K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
- •Food and Drug Administration, Orphan Drugs
- •Rare disease issues. Orphan drugs. Prescription Drug User Fee (PDUFA) reauthorization. Biosimilar User Fee Act (BsUFA) reauthorization. Food and Drug Administration facility inspections.
- •Rare disease issues. Orphan drugs. Prescription Drug User Fee (PDUFA) reauthorization. Biosimilar User Fee Act (BsUFA) reauthorization. Cancer research.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.